Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.

BACKGROUND: Children with juvenile idiopathic arthritis (JIA) are at risk of uveitis. The role of adalimumab (Humira®; AbbVie Inc., Ludwigshafen, Germany) in the management of uveitis in children needs to be determined. OBJECTIVE: To compare the efficacy, safety and cost-effectiveness of adalimumab...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Health Technol Assess
Auteurs principaux: Ramanan, Athimalaipet V, Dick, Andrew D, Jones, Ashley P, Hughes, Dyfrig A, McKay, Andrew, Rosala-Hallas, Anna, Williamson, Paula R, Hardwick, Ben, Hickey, Helen, Rainford, Naomi, Hickey, Graeme, Kolamunnage-Dona, Ruwanthi, Culeddu, Giovanna, Plumpton, Catrin, Wood, Eifiona, Compeyrot-Lacassagne, Sandrine, Woo, Patricia, Edelsten, Clive, Beresford, Michael W
Format: Artigo
Langue:Inglês
Publié: NIHR Journals Library 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511891/
https://ncbi.nlm.nih.gov/pubmed/31033434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta23150
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires